- Two industry leaders join forces to empower people living with
diabetes by providing information and insights to improve weight
loss, glucose control and overall health
- Collaboration will create a seamless, integrated experience
between Abbott's world-leading continuous glucose monitoring
device1 and WeightWatchers' number one
doctor-recommended weight loss program2 to help
individuals better understand and manage their diabetes and
PARK, Ill., Aug. 4, 2022
/PRNewswire/ -- Abbott (NYSE: ABT) and WW International, Inc.
("WeightWatchers" or "WW") today announced a strategic partnership
that will help people living with diabetes better understand and
manage their diabetes and weight. The companies are working
together to integrate WeightWatchers' diabetes-tailored weight
management program with Abbott's portfolio of FreeStyle
Libre® products to create a seamless mobile experience
that will give people living with diabetes the information and
insights needed to make healthy adjustments to their diet, improve
their glucose levels, and, ultimately, gain more control of their
Maintaining a healthy body weight and having proper nutrition
are critical to living well with diabetes.3 Yet, for
many people living with diabetes, determining what to eat and
following a meal plan is the most challenging part of diabetes
management.4 Through this partnership, participants
can receive glucose insights from Abbott's FreeStyle Libre
sensor-based technology that show the impact of food choices,
alongside the empirically validated5 WeightWatchers'
diabetes-tailored nutritional guidance to help them achieve their
healthier living goals.
"We strive to put our customers at the heart of everything we
do, and that includes forming strategic partnerships with key
industry leaders, like WeightWatchers, to provide new services and
offerings that can greatly improve the quality of life for people
living with diabetes," said Jared
Watkin, senior vice president of Abbott's diabetes care
business. "By combining our world-leading1
FreeStyle Libre glucose monitoring technology with WeightWatchers'
number one doctor-recommended weight loss program,2
people with diabetes, in particular, those with Type 2
diabetes and less intensively managed by doctors, can have the
insights they need to take control of their health."
The two companies will work together to allow Abbott's FreeStyle
Libre continuous glucose monitoring systems and the WeightWatchers
mobile app to share information so that people living with diabetes
can see their glucose data alongside WeightWatchers'
"It's proven that lifestyle changes, including shifts in
patterns of eating and activity routines, are a crucial component
of diabetes management and can help improve glycemic
control,6" said Sima
Sistani, chief executive officer of WeightWatchers. "We've
partnered with Abbott, a leader in diabetes care, to make it
possible for people with diabetes to reach their weight and healthy
living goals while enjoying the foods they love and better managing
their glucose levels."
The partnership will initially focus on solutions for people
living with diabetes within the United
States in 2023.
Abbott is a global healthcare leader that helps people live more
fully at all stages of life. Our portfolio of life-changing
technologies spans the spectrum of healthcare, with leading
businesses and products in diagnostics, medical devices,
nutritionals and branded generic medicines. Our 113,000 colleagues
serve people in more than 160 countries.
Connect with Abbott at www.abbott.com, on LinkedIn
at www.linkedin.com/company/abbott-, on Facebook at
www.facebook.com/Abbott and on Twitter @AbbottNews.
About WW International, Inc.
WeightWatchers is a
human-centric technology company powered by the world's leading
commercial weight management program. For nearly six decades, we
have inspired millions of people to adopt healthy habits for real
life. Through our comprehensive tools, expert Coaches and
community, members follow our proven, sustainable, science-based
program focused on weight loss. To learn more about the
WeightWatchers approach to healthy living, please visit ww.com. For
more information about our global business, visit our corporate
website at corporate.ww.com.
Indications and Important Safety Information
FreeStyle Libre 14 day system: Failure to use
FreeStyle Libre 14 day system as instructed in labeling may result
in missing a severe low or high glucose event and/or making a
treatment decision, resulting in injury. If readings do not match
symptoms or expectations, use a fingerstick value from a blood
glucose meter for treatment decisions. Seek medical attention when
appropriate or contact Abbott
at 855-632-8658 or FreeStyleLibre.us for safety
FreeStyle Libre 2 and FreeStyle Libre 3
systems: Failure to use FreeStyle Libre 2 or FreeStyle
Libre 3 systems as instructed in labeling may result in missing a
severe low or high glucose event and/or making a treatment
decision, resulting in injury. If glucose alarms and readings do
not match symptoms or expectations, use a fingerstick value from a
blood glucose meter for treatment decisions. Seek medical attention
when appropriate or contact Abbott
at 855-632-8658 or FreeStyleLibre.us for safety
1Data on file, Abbott Diabetes Care. Data based on
the number of users worldwide for the FreeStyle Libre portfolio
compared to the number of users for other leading personal use,
sensor-based glucose monitoring systems.
2 Based on a 2020 IQVIA survey of 14,000 doctors who
recommend weight-loss programs to patients.
3 Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK,
MacLeod J, Mitri J, Pereira RF, Rawlings K, Robinson S, Saslow L,
Uelmen S, Urbanski PB, Yancy WS Jr. Nutrition Therapy for Adults
With Diabetes or Prediabetes: A Consensus Report. Diabetes Care.
2019 May;42(5):731-754. doi: 10.2337/dci19-0014. Epub 2019 Apr 18.
PMID: 31000505; PMCID: PMC7011201.
4 American Diabetes Association. "5. Facilitating
behavior change and well-being to improve health outcomes:
standards of medical care in diabetes—2021." Diabetes care 44, no.
Supplement 1 (2021): S53-S72.
5 Apolzan JW, LaRose JG, Anton SD, et al. A Weight
Management Program Tailored for Adults with Type 2 Diabetes:
Effects on Glycemic Control. Poster presented at: American Diabetes
Association 82nd Scientific Sessions; June
5-6, 2022; New Orleans,
6 American Diabetes Association. Lifestyle Management:
Standards of Medical Care in Diabetes—2019. Diabetes Care.
View original content to download